Beijing Tiantan Biological Products Corporation Limited’s Net Profit Rose 46.3% in First Half of 2023

Beijing Tiantan Biological Products Corporation Limited (北京天坛生物制品股份有限公司) (600161.SH) reported a net profit of 774.2 million yuan in the first half of 2023, up 46.3% year-on-year.

Meanwhile, the company posted 2.7 billion yuan in revenue, up 42.3% year-on-year.

At the end of the reporting period, it had 13.9 billion yuan in total assets and 1.8 billion yuan in total liabilities, with a liability-to-asset ratio of 13.2%.